Lv13
86 积分 2023-09-15 加入
Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab
2小时前
已完结
Treatment of lupus nephritis: consensus, evidence and perspectives
3小时前
已完结
Treatment Target in Newly Diagnosed Systemic Lupus Erythematosus: The Association of Lupus Low Disease Activity State and Remission With Lower Accrual of Early Damage
3小时前
已完结
The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus
3小时前
已完结
Evaluation of systemic lupus erythematosus activity: an update
4小时前
已完结
Relationship between disease activity, organ damage and health-related quality of life in patients with systemic lupus erythematosus: A systemic review and meta-analysis
6小时前
已完结
Incidence and prevalence of systemic lupus erythematosus in urban China, 2013–2017: A nationwide population-based study
7小时前
已完结
Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study
1天前
已完结
Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006
2天前
已完结
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
7天前
已完结
皖公网安备34019202002308
